Company intelligence / Profile preview

Dim3

Beaufays, Liège, Belgiumdim3.com ↗

Ownership: Private
Development stage: Commercial

Overview

Dim3 develops ISO13485-certified medical devices—both hardware and software—that enable doctors, dietitians, and nurses to detect malnutrition risks, simulate personalized nutrition plans, set optimal intakes, and monitor patient progress in real time. Their solutions aim to improve care quality while reducing costs associated with malnutrition across Europe. The company works closely with clinicians from multiple countries to ensure their technology meets real-world needs.

Therapeutic areas: Metabolic Disorders
Industry: Digital Health Medical Devices

Beyond the preview

Go deeper on Dim3.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dim3.

Explore the full profile